Links
Networked Blogs
Search maven&meddler for content below

 

America’s Unions - For American Workers

 

 

 

     
Maven is a Survivor


 

 

Powered by FeedBurner

Blogarama - Blog Directory

Subscribe to RSS headline updates from:
Powered by FeedBurner

 

Loading..

 

 

 

 

This form does not yet contain any fields.
    Powered by Squarespace

    Entries in HRT (2)

    Monday
    Oct192009

    Truth: Hormone replacement therapy increases your risk of breast cancer

    TRUE. According to the Women’s Health Initiative (WHI) Postmenopausal Hormone Therapy Trials, an estrogen-plus-progestin replacement therapy increases the risk of breast cancer, along with heart disease, stroke and blood clots.

    The WHI clinical trials, launched in 1991, studied a group of 161,808 generally healthy postmenopausal women for the effects of HRT, diet modification and calcium and vitamin D supplement use on heart disease, fractures, and breast and colorectal cancer. Results from the trial on HRT, published in 2002, found that while the estrogen-only replacement therapy did not increase breast cancer risk, the risks far outweighed the benefits in the estrogen-plus-progestin study. Overall, there was a 24% increase in the risk for breast cancer due to estrogen-plus-progestin.

    Learn more about this type of scientific study and NBCC’s involvement in clinical trials by reading about NBCC’s Clinical Trials Initiative.

    Finally, in each breast cancer post this month I’m going to make this point, and I want you to listen very carefully:

    Did you just get the bad news? Get a second opinion now. Do not let anybody rush you into anything and that includes a biopsy. Do not do it.

    The only reason I sit here today is because I had the good fortune to get a second opinion before I proceeded with anything. The first opinion was wildly wrong, and could well have cost me my life!

    Get a second, or even a third opinion - preferably out of your area.

    maven

    Tuesday
    Dec232008

    Hormone replacement therapy and risk

    SAN ANTONIO, Dec. 16 — The elevated breast cancer risk from hormone replacement therapy quickly dissipates after combined estrogen and progestin is discontinued, researchers reported here.

    Click to read more ...